Blowfish: FDA Approves Hangover Cure (No It's Not Fugu)
Conveniently in time for this weekend's New Year's Eve festivities, the FDA has finally approved a hangover cure: a pill called Blowfish. Designed by Brenna Haysom, a Manhattan-based Harvard Business School grad, and developed by Rally Labs LLC, the pill is a combination of aspirin and caffeine and was made to alleviate, well, what you'd think it would: the pain and fatigue of drinking a hell of a lot more than you probably should have.
Why is it called Blowfish? And why can't you just chug some espresso with a few actual aspirin? Ah, the mysteries of advertising. Blowfish, which is meant to be taken the morning after your bender, is kind of like Alka-Seltzer (tablets, fizz) and contains 1000 mg of aspirin and 120 mg of caffeine -- in layman's terms, that would be a cup of coffee and, um, some aspirin. Haysom ("Before dedicating my life to hangovers, I was a normal New Yorker") writes on the website that she tried lots of herbal remedies, but found that this combination worked the best. Why not. It's probably a lot better than actual blowfish for curing hangovers, although death-by-fugu could be considered the ultimate hangover cure -- especially considering the amount of sake some people consume with the stuff.
A footnote: If Urasawa's fugu is too pricey for you, pick up some dried blowfish the next time you're in Kyoto. Not only is it considerably cheaper, but it looks like it's been spun from sugar. Not a bad thing in a potentially deadly bar snack.
Get the Squid Ink'd Newsletter
Sign up for our weekly food newsletter, which features top local food news and events, plus interviews with chefs and restaurant owners, dining tips and a link to our print review.